The current financial score of GoodRx Holdings Inc is 7.84. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 200.41M, representing a year-over-year decrease of 1.31%, while its net profit experienced a year-over-year decrease of 33.54%.
The current valuation score of GoodRx Holdings Inc is 6.17. Its current P/E ratio is 56.78, which is 465.60% below the recent high of 321.17 and 1067.39% above the recent low of -549.32.
The current earnings forecast score of GoodRx Holdings Inc is 6.67. The average price target is 4.03, with a high of 5.00 and a low of 2.65.
The current price momentum score of GoodRx Holdings Inc is 3.33. Currently, the stock price is trading between the resistance level at 3.69 and the support level at 3.18, making it suitable for range-bound swing trading.
The current institutional shareholding score of GoodRx Holdings Inc is 5.00. The latest institutional shareholding proportion is 60.63%, representing a quarter-over-quarter decrease of 29.11%.
The current risk assessment score of GoodRx Holdings Inc is 5.27. The company's beta value is 1.61. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.